With a coronavirus vaccine still months off, companies are rushing to test what may be the next best thing.
In this May 2020 photo provided by Eli Lilly, a researcher tests possible COVID-19 antibodies in a laboratory in Indianapolis. Antibodies are proteins the body makes when an infection occurs; they attach to a virus and help it be eliminated.
These drugs are believed to last for a month or more and could give quick, temporary immunity to people at high risk of infection, such as health workers and housemates of someone with COVID-19. If they proved effective and if a vaccine doesn’t materialize or protect as hoped, the drugs might eventually be considered for wider use, perhaps for teachers or other groups.
“Our goal is to get something out as soon as possible” and to have hundreds of thousands of doses ready by fall, said Lilly’s chief scientific officer, Dr. Daniel Skovronsky. Lilly is testing two different, single-antibody drugs — one with the Canadian company AbCellera and another with a Chinese company, Junshi Biosciences. In July, Junshi said no safety concerns emerged in 40 healthy people who tried it and that larger studies were getting underway.
Deutschland Neuesten Nachrichten, Deutschland Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
Companies test antibody drugs to treat, prevent COVID-19With a coronavirus vaccine still months off, companies are rushing to test what may be the next best thing: drugs that deliver antibodies to fight the virus right away, without having to train the...
Weiterlesen »
If You Get Covid-19 Overseas, This Startup Will Bring You Home When Other Companies Won’tRun by a team straight out of a Tom Clancy novel, a new company aims to give international travelers peace of mind during the pandemic.
Weiterlesen »
Coronavirus updates: US records more than 1,000 new deaths from COVID-19CORONAVIRUS LATEST: — U.S. records more than 1,000 new deaths from COVID-19. — Nearly one-third of Kentucky's new cases among teens.
Weiterlesen »
Will Insurers Pay for Telehealth When COVID-19 is Over?Hospital-style care iTelehealth options exploded during Covid, but will insurers continue to pay for it when it's over?
Weiterlesen »
Private equity funding plummets in COVID-19: Experts say it's a blip - Business InsiderPrivate-equity fundraising hit a 2-year low in Q2 as coronavirus wreaked havoc with businesses and travel. We spoke to experts about why the drop is a 'pause, rather than a wholesale change.'
Weiterlesen »